Skip to content

Clinical trials

Phase 1 Recurrence trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 1 Country / region: Belgium Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20141
20151
20161
20171
20181
20201
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting5
Terminated5
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Menarini Group2
AbbVie1
Bayer1
Byondis B.V.1
Celyad Oncology SA1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
Genmab1
Ipsen1
Janssen Research & Development, LLC1
Merus B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence12
Leukemia, Myeloid, Acute3
Lymphoma, Non-Hodgkin3
Neoplasm Metastasis3
Squamous Cell Carcinoma of Head and Neck3
Multiple Myeloma2
Amyloidosis1
Bone Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.